Filing
Spy
Filing
Spy
Home
About
MRK
Merck & Co., Inc.
Global research-intensive biopharmaceutical company
CUSIP: 589331107
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2019 Q4
9 of 35 quarters
Total Value
$94.41B
Total Shares
1.04M
Net Share Change
-984.5K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Kahn Brothers Group
$94.41B
1.04M
11.4%
TRIM
-984.5K
(-48.7%)
Kahn Brothers Group
$94.41B
1.04M shares
TRIM
-984.5K
(-48.7%)
MRK — Merck & Co., Inc. - FilingSpy